EUVIMEDEUVIMED entdecken
Fallbericht

Clear cell tumor with melanocytic differentiation and MITF::CREM translocation

Sanda Alexandrescu, Alma Imamovic-Tuco, Katherine Janeway, John Hanna

Journal of Cutaneous Pathology · 2023

DOI: 10.1111/cup.14427 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Cutaneous Pathology, 2023. Verfasst von Sanda Alexandrescu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Sarcoma, Clear Cell, Melanoma. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Bertarelli Rare Cancers Fund at Harvard Medical School.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In addition to melanoma, a large and diverse family of tumors shows melanocytic differentiation. The best characterized member of this family is clear cell sarcoma, which is characterized by EWSR1::ATF1 and EWSR1::CREB1 fusions. These fusions drive the transcription of MITF , the master regulator of melanocytic differentiation. Clear cell tumor with melanocytic differentiation and MITF::CREM translocation is a recently described tumor with some similarities to clear cell sarcoma. However, only a single case has been reported. Here, we describe a second molecularly proven case that arose on the scalp of a newborn baby. In contrast to the prior reported case, the current case showed predominantly high‐grade cytomorphologic features with only focal clear cell areas. Similar to the prior case, the tumor showed immunohistochemical evidence of neural crest origin/differentiation with prominent melanocytic differentiation. The fusion breakpoints were also similar and preserved the transcriptional activation domain of CREM, suggesting that CREM hyperactivity is a major feature of this tumor type. The current tumor showed a short‐interval recurrence. These results expand the clinical and pathologic spectrum of this potentially new entity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sarcoma, Clear CellMelanomaInfant, NewbornHumansTranslocation, GeneticCell DifferentiationOncogene Proteins, FusionMicrophthalmia-Associated Transcription FactorCyclic AMP Response Element Modulator

Stichwörter der Autor:innen

CREMMITFclear cell sarcomafusionmelanocytic

Substanzen

Oncogene Proteins, FusionMITF protein, humanMicrophthalmia-Associated Transcription FactorCREM protein, humanCyclic AMP Response Element Modulator

Autor:innen und Institutionen

  • Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Department of Hematology and Oncology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Förderung

  • Bertarelli Rare Cancers Fund at Harvard Medical School

Zitieren

APA

Alexandrescu, S., Imamovic-Tuco, A., Janeway, K., & Hanna, J. (2023). Clear cell tumor with melanocytic differentiation and MITF::CREM translocation. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14427

Vancouver

Alexandrescu S, Imamovic-Tuco A, Janeway K, Hanna J. Clear cell tumor with melanocytic differentiation and MITF::CREM translocation. Journal of Cutaneous Pathology. 2023. doi:10.1111/cup.14427

BibTeX
@article{Alexandrescu2023,
  author = {Alexandrescu, Sanda and Imamovic-Tuco, Alma and Janeway, Katherine and Hanna, John},
  title = {Clear cell tumor with melanocytic differentiation and MITF::CREM translocation},
  journal = {Journal of Cutaneous Pathology},
  year = {2023},
  doi = {10.1111/cup.14427}
}
Kostenlos starten →